Efficacy of Me-Cal in osteoporosis patients as compared to standard calcium supplement
- Conditions
- Health Condition 1: null- OSTEOPOROSIS
- Registration Number
- CTRI/2018/01/011309
- Lead Sponsor
- SG PHYTO PHARMA PVT LTD
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Patients complaining of classical symptoms of
joint pain, pain in the bones etc. which will
be confirmed later by the BMD-test with BMD
score below -1.
2. Patient agrees not to use any other calcium
supplement for osteoporosis other than what is
provided by the study.
3. Patient agrees to written informed consent.
4. Patient willing to participate in the study
for 12 weeks.
5. Patient who has not participated in any
clinical study in last 30 days.
1.Planning to conceive, pregnant and lactating mothers.
2. Patient under osteoporosis treatment.
3. Patients suffering from heart disease.
4. Patients with severe renal impairment.
5. Patient with known metabolic bone disease such
as osteogenesis imperfecta, or currently
healing fractures of lumbar spine, hips or
femurs.
6. Patient on current treatment with steroids or
chemotherapy.
7. History of malignancy
8. History of hypersensitivity to any of the investigational drugs.
9. History of psychiatric disorder that may impair the ability of subjects to provide written informed consent
10. Any medical condition, where the investigator feels participation in the study could be detrimental to the subjects overall well-being.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method